bioXXmed AG (FRA:T5O0)

Market Cap	72.72K
Revenue (ttm)	20.49K
Net Income (ttm)	-890.91K
Shares Out	1.36M
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	623
Average Volume	189
Open	0.0535
Previous Close	0.0035
Day's Range	0.0535 - 0.0535
52-Week Range	0.0010 - 2.6000
Beta	1.19
RSI	47.36
Earnings Date	Dec 19, 2025

About bioXXmed AG

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 1
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: T5O0

Financial Performance

In 2024, bioXXmed AG's revenue was 3,493, a decrease of -79.93% compared to the previous year's 17,404. Losses were -996,907, -95.24% less than in 2023.